Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox    CLX

CLOROX (CLX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CEST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX
04/20P&G's vitamin boost could signal more to come
RE
04/20CLOROX : Today’s Research Reports on Stocks to Watch: The Clorox Company and Pro..
AC
04/19CLOROX : Announces May 8 Webcast of Company Presentation at Goldman Sachs Global..
PR
04/02CLOROX CO /DE/ : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
03/30CLOROX : DE/ Change in Directors or Principal Officers (form 8-K/A)
AQ
03/30CLOROX CO /DE/ : Change in Directors or Principal Officers (form 8-K)
AQ
03/30BRITA : ® And Stephen Curry Seek To Make A Long-Lasting Impact In Schools Nation..
PR
03/29CLOROX : Patent Application Titled "Continuous Spray Dispenser for Highly Corros..
AQ
03/28CLOROX : Announces May 2 Webcast of Third-Quarter Fiscal Year 2018 Results
PR
03/27CLOROX : Green Biologics Partners With Kingsford® Charcoal to Launch New EcoLigh..
PR
More news
News from SeekingAlpha
04/21THE PASSIVE DGI CORE PORTFOLIO : Income, Safety, And Growth 
04/19P&G earnings weigh on household products stocks 
04/17PROCTER & GAMBLE : The Good, The Bad And The Ugly 
04/13THE DIVIDEND DIET : A Guide To Investing On Easy Street 
04/1332 'Safer' Dividend Consumer Defensive Stocks For April, 2019 
Financials ($)
Sales 2018 6 144 M
EBIT 2018 1 134 M
Net income 2018 795 M
Debt 2018 1 840 M
Yield 2018 3,00%
P/E ratio 2018 18,77
P/E ratio 2019 17,97
EV / Sales 2018 2,72x
EV / Sales 2019 2,59x
Capitalization 14 866 M
Chart CLOROX
Duration : Period :
Clorox Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Technical analysis trends CLOROX
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 134 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby Chief Operating Officer & Executive VP
Kevin Jacobsen Chief Financial Officer & Senior Vice President
Manjit Singh Chief Information Officer & Senior Vice President
Robert W. Matschullat Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX-19.89%14 866
UNILEVER INDONESIA TBK PT--.--%28 086
CHURCH & DWIGHT CO-8.63%11 191
KOBAYASHI PHARMACEUTICAL CO LTD23.36%6 882
LION CORP8.71%6 488
WD-40 COMPANY12.67%1 831